Bipartisan Senate psychedelics bill; MS gov vetoes medical marijuana expansion; IN gov talks legalization; Poll: Cannabis use isn’t immoral
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Rep. Steve Cohen (D-TN) sent a letter pressing Attorney General Pam Bondi and Drug Enforcement Administration Administrator Terrance Cole for an update on where marijuana rescheduling stands three months after President Donald Trump issued an order directing it be completed in “the most expeditious manner.”
- The letter also asks about the Department of Justice missing a statutory deadline to issue guidelines on easing research barriers into Schedule I drugs like cannabis and psychedelics.
Sens. Tim Sheehy (R-MT), Tammy Duckworth (D-IL), Ruben Gallego (D-AZ) and John Boozman (R-AR) filed a bill to create a new Department of Veterans Affairs office that would promote research on psychedelics and assist in reviewing scheduling status of drugs like psilocybin, ibogaine and MDMA.
Mississippi Gov. Tate Reeves (R) vetoed two bills to expand medical cannabis access but signed separate legislation to support research on the psychedelic ibogaine.
Indiana Gov. Mike Braun (R) blamed Republican legislative leaders for refusing to reform marijuana laws while “over half of Hoosiers probably smoke it illegally”—but said he thinks the “crescendo will rise” in the call for legalization.
A new poll shows that a majority of Americans across every age, gender, religion and political demographic agree that using marijuana is not morally wrong—but that Republicans are still twice as likely as Democrats to say consuming cannabis is a moral no-no.
Kansas’s attorney general and other law enforcement officials are being sued by smoke and vape shops that say they failed to distinguish between legal hemp and illegal cannabis products during recent raids on their businesses.
Here’s a look at what newly enacted restrictions on marijuana and hemp products mean for consumers and businesses.
/ FEDERAL
The Drug Enforcement Administration posted another profile of one of its special agents.
Rep. Alexandria Ocasio-Cortex (D-NY) is being accused of improperly spending nearly $19,000 in campaign funds on a therapist who specializes in ketamine therapy.
The House bill to provide a pathway for patients to access Schedule I drugs got one new cosponsor for a total of 17.
/ STATES
Utah Gov. Spencer Cox (R) signed bills to amend medical cannabis rules.
Minnesota Gov. Tim Walz (D) signed a bill to allow businesses manufacturing lower-potency hemp edibles to temporarily continue using out-of-state testing facilities.
The Oklahoma House of Representatives rejected a bill to allow counties to tax medical cannabis.
The Pennsylvania Supreme Court ruled that a cannabis trade association does not have standing to challenge a local court’s rule restricting people who are on probation from using medical cannabis.
California regulators announced a recall of marijuana products due to inner packaging that is missing required labeling.
New Jersey’s top cannabis regulator is stepping down.
New Mexico regulators released draft psilocybin program rules.
The New Jersey Cannabis Regulatory Commission will meet on Tuesday.
The New York Cannabis Control Board will meet on Thursday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
A San Francisco, California supervisor is pushing a proposal to halt funding for new permanent supportive housing facilities that are unwilling to evict residents over drug use.
/ INTERNATIONAL
A former German health minister tweeted, “Just as (also predicted by me) before: cannabis consumption does not rise with legalization, and the crime rate drops dramatically. Legalization was right. Stamping young adults as criminals for cannabis consumption was simply unfair.”
/ SCIENCE & HEALTH
A review concluded that “exogenous cannabinoids show beneficial effects in pre-clinical [inflammatory bowel disease] models, likely through anti-inflammatory, antioxidant, and barrier-enhancing mechanisms.”
A study “demonstrates that psilocybin reduces aggression and activity in an emerging fish model, adding to the evidence supporting its potential as a therapeutic agent for future clinical translation.”
/ BUSINESS
iAnthus Capital Holdings, Inc. reported quarterly revenue of $35.3 million and a net loss of $14.1 million.
Jushi Holdings Inc. completed refinancing of its former senior secured credit facility and its former second lien credit facility through the issuance of a $160 million senior secured term loan.
/ CULTURE
Bob Marley’s heirs are suing Tilray Brands Inc. over millions in payments tied to a deal licensing his name, image and likeness.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
